CLPBF
Price
$94.55
Change
-$0.86 (-0.90%)
Updated
Aug 13 closing price
Capitalization
21.19B
CLPBY
Price
$9.49
Change
+$0.12 (+1.28%)
Updated
Aug 15 closing price
Capitalization
21.19B
3 days until earnings call
Interact to see
Advertisement

CLPBF vs CLPBY

Header iconCLPBF vs CLPBY Comparison
Open Charts CLPBF vs CLPBYBanner chart's image
Coloplast AS
Price$94.55
Change-$0.86 (-0.90%)
Volume$10
Capitalization21.19B
Coloplast AS
Price$9.49
Change+$0.12 (+1.28%)
Volume$137.47K
Capitalization21.19B
CLPBF vs CLPBY Comparison Chart in %
Loading...
CLPBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLPBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLPBF vs. CLPBY commentary
Aug 17, 2025

To understand the difference between Coloplast AS - Ordinary Shares - Class B (CLPBF) vs. Coloplast AS - ADR (CLPBY) it is enough to know the definitions of Ordinary Shares - Class B and ADR

Ordinary Shares - Class B - Generally, Class B shares are issued by a company as a common stock with fewer voting rights and lower dividend priority than Class A shares. Class B may also have lower repayment priority in the event of a bankruptcy.

ADR - American depositary receipt (ADR) is a certificate issued by a U.S. depositary bank representing a specified number of shares (often 1 share) of a foreign company's stock. ADRs are denominated in U.S. dollars and trade on U.S. stock markets and OTC depending on the ADRs classification.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 17, 2025
Stock price -- (CLPBF: $94.54 vs. CLPBY: $9.49)
Brand notoriety: CLPBF and CLPBY are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CLPBF: 3% vs. CLPBY: 54%
Market capitalization -- CLPBF: $21.19B vs. CLPBY: $21.19B
CLPBF [@Pharmaceuticals: Other] is valued at $21.19B. CLPBY’s [@Pharmaceuticals: Other] market capitalization is $21.19B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $172.16B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLPBF’s FA Score shows that 1 FA rating(s) are green whileCLPBY’s FA Score has 1 green FA rating(s).

  • CLPBF’s FA Score: 1 green, 4 red.
  • CLPBY’s FA Score: 1 green, 4 red.
According to our system of comparison, both CLPBF and CLPBY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLPBF’s TA Score shows that 5 TA indicator(s) are bullish while CLPBY’s TA Score has 5 bullish TA indicator(s).

  • CLPBF’s TA Score: 5 bullish, 2 bearish.
  • CLPBY’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, CLPBF is a better buy in the short-term than CLPBY.

Price Growth

CLPBF (@Pharmaceuticals: Other) experienced а +2.11% price change this week, while CLPBY (@Pharmaceuticals: Other) price change was +0.42% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.53%. For the same industry, the average monthly price growth was -0.29%, and the average quarterly price growth was +4.24%.

Reported Earning Dates

CLPBY is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.53% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLPBF($21.2B) and CLPBY($21.2B) have the same market capitalization . CLPBY (29.97) and CLPBF (29.85) have similar P/E ratio . CLPBY YTD gains are higher at: -11.924 vs. CLPBF (-12.686). CLPBF (8.66B) and CLPBY (8.66B) have comparable annual earnings (EBITDA) . CLPBF (729M) and CLPBY (729M) have equal amount of cash in the bank . CLPBF (24.3B) and CLPBY (24.3B) have identical debt. CLPBF (27.8B) and CLPBY (27.8B) have equivalent revenues.
CLPBFCLPBYCLPBF / CLPBY
Capitalization21.2B21.2B100%
EBITDA8.66B8.66B100%
Gain YTD-12.686-11.924106%
P/E Ratio29.8529.97100%
Revenue27.8B27.8B100%
Total Cash729M729M100%
Total Debt24.3B24.3B100%
FUNDAMENTALS RATINGS
CLPBF vs CLPBY: Fundamental Ratings
CLPBF
CLPBY
OUTLOOK RATING
1..100
677
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
15
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
3535
PRICE GROWTH RATING
1..100
6262
P/E GROWTH RATING
1..100
8484
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CLPBF's Valuation (15) in the null industry is in the same range as CLPBY (15). This means that CLPBF’s stock grew similarly to CLPBY’s over the last 12 months.

CLPBF's Profit vs Risk Rating (100) in the null industry is in the same range as CLPBY (100). This means that CLPBF’s stock grew similarly to CLPBY’s over the last 12 months.

CLPBF's SMR Rating (35) in the null industry is in the same range as CLPBY (35). This means that CLPBF’s stock grew similarly to CLPBY’s over the last 12 months.

CLPBF's Price Growth Rating (62) in the null industry is in the same range as CLPBY (62). This means that CLPBF’s stock grew similarly to CLPBY’s over the last 12 months.

CLPBF's P/E Growth Rating (84) in the null industry is in the same range as CLPBY (84). This means that CLPBF’s stock grew similarly to CLPBY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLPBFCLPBY
RSI
ODDS (%)
Bearish Trend 2 days ago
68%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
50%
Bearish Trend 2 days ago
60%
Momentum
ODDS (%)
Bullish Trend 2 days ago
54%
Bullish Trend 2 days ago
57%
MACD
ODDS (%)
Bullish Trend 2 days ago
52%
Bullish Trend 2 days ago
63%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
54%
Bullish Trend 2 days ago
58%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
52%
Bullish Trend 2 days ago
58%
Advances
ODDS (%)
N/A
Bullish Trend 12 days ago
61%
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
56%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
64%
Aroon
ODDS (%)
Bullish Trend 2 days ago
48%
Bullish Trend 2 days ago
46%
View a ticker or compare two or three
Interact to see
Advertisement
CLPBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLPBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EDIV39.060.14
+0.36%
SPDR® S&P Emerging Markets Dividend ETF
PPEM25.480.01
+0.04%
Putnam PanAgora ESG Emerg Mkts Eq ETF
PBJL28.98N/A
N/A
PGIM S&P 500 Buffer 20 ETF - Jul
BSV78.61-0.01
-0.01%
Vanguard Short-Term Bond ETF
DBO13.24-0.17
-1.27%
Invesco DB Oil

CLPBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLPBF has been loosely correlated with CLPBY. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CLPBF jumps, then CLPBY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLPBF
1D Price
Change %
CLPBF100%
N/A
CLPBY - CLPBF
38%
Loosely correlated
+1.28%
AHICF - CLPBF
26%
Poorly correlated
N/A
WILLF - CLPBF
22%
Poorly correlated
+2.41%
QDEL - CLPBF
20%
Poorly correlated
-0.08%
ESLOY - CLPBF
20%
Poorly correlated
+1.92%
More

CLPBY and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLPBY has been loosely correlated with CLPBF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CLPBY jumps, then CLPBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLPBY
1D Price
Change %
CLPBY100%
+1.28%
CLPBF - CLPBY
38%
Loosely correlated
N/A
SAUHY - CLPBY
34%
Loosely correlated
+0.70%
SMMNY - CLPBY
33%
Poorly correlated
+0.81%
SONVY - CLPBY
32%
Poorly correlated
+0.21%
ESLOY - CLPBY
32%
Poorly correlated
+1.92%
More